Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Non Operating Income (2020 - 2024)

RAPT Therapeutics' Non Operating Income history spans 5 years, with the latest figure at $1.2 million for Q4 2024.

  • For Q4 2024, Non Operating Income fell 48.06% year-over-year to $1.2 million; the TTM value through Dec 2024 reached $6.2 million, down 39.24%, while the annual FY2024 figure was $6.2 million, 39.24% down from the prior year.
  • Non Operating Income for Q4 2024 was $1.2 million at RAPT Therapeutics, down from $1.4 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $3.1 million in Q2 2023 and bottomed at -$275000.0 in Q2 2022.
  • The 5-year median for Non Operating Income is $496000.0 (2020), against an average of $988700.0.
  • The largest YoY upside for Non Operating Income was 1309.52% in 2022 against a maximum downside of 848.28% in 2022.
  • A 5-year view of Non Operating Income shows it stood at $549000.0 in 2020, then plummeted by 80.87% to $105000.0 in 2021, then soared by 1309.52% to $1.5 million in 2022, then soared by 58.18% to $2.3 million in 2023, then crashed by 48.06% to $1.2 million in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Non Operating Income are $1.2 million (Q4 2024), $1.4 million (Q3 2024), and $1.7 million (Q2 2024).